Latest filing published 12 Dec 2025 for Turn Therapeutics Inc., €7,454.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Zuraiz Chaudhary on record concern Turn Therapeutics Inc. The record holds 4 filings, for trades running from 23 October 2025 to 12 December 2025.
On the market, this insider has only ever bought: 4 purchases, €40k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €7,622 and half below. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was +3.7%. These figures describe past trades and do not predict future prices.
On 12 December 2025 came the latest disclosure, an open-market purchase for €7,454 in Turn Therapeutics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations